Pilot Study of the Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Darunavir (Primary) ; Raltegravir (Primary) ; Ritonavir (Primary) ; Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 28 Apr 2011 Biomarkers information updated
- 27 Apr 2011 New trial record